AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04704778 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: PLACEBO_COMPARATOR
Intervention: Oclusal splint
Description: The occlusal splint is worn 24 hours a day, removed for eating and brushing teeth. It is washed with neutral liquid hand soap.~For the preparation, an impression of the maxillary dental arches will be taken with alginate; It is made with acetate .060 and .080.~Relining is done with self-curing acrylic on the occlusal surface of the splint
Study NCT04704778 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Oclusal splint
Description: The occlusal splint is worn 24 hours a day, removed for eating and brushing teeth. It is washed with neutral liquid hand soap.~For the preparation, an impression of the maxillary dental arches will be taken with alginate; It is made with acetate .060 and .080.~Relining is done with self-curing acrylic on the occlusal surface of the splint
Study NCT05557773 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Home Based Traditional Scoliosis Exercises
Description: Patients in this group will receive posture exercises, strengthening exercises, diaphragmatic breathing exercises and stretching exercises.
Study NCT05557773 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Home Based Traditional Scoliosis Exercises
Description: Patients in this group will receive posture exercises, strengthening exercises, diaphragmatic breathing exercises and stretching exercises.
Study NCT05557773 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Core Stability Training
Description: Patients in this group will receive traditional scoliosis exercises. In addition, the training group will receive core stabilization exercises for multifidus, diaphragm,erector spines, rectus abdominis, internal and external obliques, quadratus lumborum, iliopsoas, gluteus maximus, and pelvic floor muscles.
Study NCT06262542 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: moxibustion and Chinese herbal medicine group
Description: Apply 15g of Chinese herbal powder (a mixture of scientific Chinese herbs: Jiseng Shenqi Pill, Xuanfu Daizheshi Tang, and Wendi Tang mixed in a 1:1:1 ratio, mixed with water to form a paste) to the Shénquè acupoint. Then, use 3g of 80:1 moxa wool placed in a moxibustion box for moxibustion on the lower abdomen (between the Guānyuán, Zhōngjí, and Shénquè acupoints) for 1 hour, once a day, six times a week, for a total of 12 sessions.~sham moxibustion and placebo herbal medicine group): Same acupoint frequency, but use 15g of flour instead of herbal paste and replace moxibustion with a heated nightlight for sham moxibustion.
Study NCT05364437 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Dietary Fibres Mix
Description: The Fibre Mix, which comprises of a mix of dietary fibres (inulin, pectin and oat beta-glucan) will need to be taken by participants twice daily for 2 weeks with their usual food.
Study NCT05364437 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: The placebo, which comprises of cellulose will need to be taken by participants twice daily for 2 weeks with their usual food.
Study NCT06262542 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: moxibustion and Chinese herbal medicine group
Description: Apply 15g of Chinese herbal powder (a mixture of scientific Chinese herbs: Jiseng Shenqi Pill, Xuanfu Daizheshi Tang, and Wendi Tang mixed in a 1:1:1 ratio, mixed with water to form a paste) to the Shénquè acupoint. Then, use 3g of 80:1 moxa wool placed in a moxibustion box for moxibustion on the lower abdomen (between the Guānyuán, Zhōngjí, and Shénquè acupoints) for 1 hour, once a day, six times a week, for a total of 12 sessions.~sham moxibustion and placebo herbal medicine group): Same acupoint frequency, but use 15g of flour instead of herbal paste and replace moxibustion with a heated nightlight for sham moxibustion.
Study NCT06224023 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Determination of presepsin levels in ascites
Description: A diagnostic paracentesis will be performed and presepsin level will be determined in ascites.
Study NCT06262659 — intervention group
Intervention type: OTHER
Intervention: Doppler Ultrasonography Assessment
Description: Preoperative data will be collected from the latest available data within the last month. Preoperative Doppler ultrasonography venous mapping for all patients will be performed by experienced Radiology Specialists.~AVF flow measurement will be performed intraoperatively and at the 6th week postoperatively using Doppler ultrasonography (B-Mode and duplex ultrasound on the LOQIC; GE Healthcare Technologies, Milwaukee, Wisconsin, United States). For each patient, AVF flows will be recorded by taking at least 3 measurements of AVF flow, depth, and vascular diameters at 2, 5, 10, and 15 cm proximal to the AVF anastomosis, and arithmetic averages will be calculated. AVF flow will be expressed in ml/min, and the vascular structure diameters and the distance of AVF from the skin will be indicated in mm. AVF depth will be calculated as the distance from the skin to the anterior wall of the AVF.
Study NCT05792020 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Focused Ultrasound Stimulation
Description: This aim will test whether motor tFUS parameters thought to be excitatory (50% duty cycle) vs. inhibitory (5% duty cycle) elicit their predicted effects on MEPs before and after each of three stimulation blocks, using 50 MEPs at each time point.
Study NCT05792020 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Focused Ultrasound Stimulation
Description: This aim will test whether motor tFUS parameters thought to be excitatory (50% duty cycle) vs. inhibitory (5% duty cycle) elicit their predicted effects on MEPs before and after each of three stimulation blocks, using 50 MEPs at each time point.
Study NCT05503082 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ubrogepant 50 MG [Ubrelvy]
Description: Ubrogepant 50 MG \[Ubrelvy\]
Study NCT05503082 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Ubrogepant 50 MG [Ubrelvy]
Description: Ubrogepant 50 MG \[Ubrelvy\]
Study NCT05503082 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ubrogepant 100 MG [Ubrelvy]
Description: Ubrogepant 100 MG \[Ubrelvy\]
Study NCT05503082 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Ubrogepant 100 MG [Ubrelvy]
Description: Ubrogepant 100 MG \[Ubrelvy\]
Study NCT05535530 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Active PSIO
Description: new designed active orthopedic appliance will be used. Impressions will be taken before starting the treatment (T1) and at the end of treatment (T2) three months later. The effectiveness of the two appliances will be assessed and measured on digital models of the maxillary arch before and after the treatment.
Study NCT05197777 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: tDCS associated to functional activities
Description: The intervention will start by a pretest on the first day (day 0, baseline record). Tdcs will be applied associated functional task from an experimental workstation, consisting in a hairdressing dummy head fixed to a telescopic table, adjustable to each individual's height. Elbow angles will be adjusted in a static position with a manual goniometer (60 degrees). The task will be performed in a standing position inside a 1m2 perimeter during 30 minutes, undergoing repetitive movements. Performing a repetitive manual gesture. The cycle will be executed at a cadence of 30s/cycle with a metronome beat. The TCT - tDCS Stimulator Kit Research version, with 35 cm2 on M1 of the contralateral hemisphere for the rigth dominant hand. During the first 30 s of active tDCS, an initial period of ''ramping up'' is administered, in which the stimulator reaches the maximum programmed current (2 mA) to mimic cutaneous perceptions. A 2 mA intensity will be maintained during activity.
Study NCT05197777 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conservative physiotherapy
Description: Education and exercices for pain relief by usual tradicional physiotherapy in Hospital: walking, mobility, and transfert.
Study NCT04682509 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Glecaprevir/pibrentasvir
Description: Manufacturer is AbbVie, Inc., North Chicago, IL Mavyret® is commercially available and FDA approved for the treatment of HCV genotype 1, 2, 3, 4, 5, or 6 infection in patients without cirrhosis or with compensated cirrhosis and also for the treatment of adult patients with HCV genotype 1 infection who previously have been treated with a regimen containing an HCV NS5A inhibitor or an NS3/4A protease inhibitor. An immediate release bilayer oral tablet containing a fixed-dose combination of 100 mg of glecaprevir and 40 mg of pibrentasvir. The daily dose of glecaprevir/pibrentasvir used will be the standard FDA approved dose: 3 tablets taken once daily (total daily dose: glecaprevir 300 mg and pibrentasvir 120 mg).
Study NCT04737850 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hetrombopag
Description: Thrombopoietin receptor agonist
Study NCT04737850 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo with no active pharmaceutical ingredient
Study NCT04910932 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Breathing Exercises
Description: Breathing exercises including diaphragmatic breathing, thoracic expansion and breathing control exercises
Study NCT04910932 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Information on COVID-19
Description: Information about COVID-19 based on the advices in COVID-19 advice for the public section of World Health Organization website.
Study NCT04910932 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Information on COVID-19
Description: Information about COVID-19 based on the advices in COVID-19 advice for the public section of World Health Organization website.
Study NCT06553183 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: immersive virtual reality
Description: Exercise based on virtual reality video games. Immersive type will be used.
Study NCT06553183 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: traditional physicaltherapy
Description: pneumatic compression, exercise and skin care
Study NCT06553183 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: traditional physicaltherapy
Description: pneumatic compression, exercise and skin care
Study NCT06423287 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Lactobacillus plantarum LP-KFY04
Description: Patients in the treatment group will be instructed to eat in an 8-hour time window (a set period of time decided by the patients) with supplementation of Lactobacillus plantarum LP-KFY04 over 12 weeks' trial.
Study NCT06423287 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Take placebo in addition to the limited diet.
Description: Patients in the control group will be instructed to eat in an 8-hour time window (a set period of time decided by the patients) with supplementation of placebo over 12 weeks'trial.
Study NCT05120960 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: tepotinib
Description: Given by PO
Study NCT05120960 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: tepotinib plus osimertinib
Description: Given by PO
Study NCT06449872 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Obstetrics and Gynecology clinical applications for ultrasound diagnostic systems
Description: Up to 5 healthcare professionals trained and experienced in Obstetrics and Gynaecology ultrasound qualitatively assessed the diagnostic image quality of the Kosmos Diagnostic Ultrasound System against the benchmark Mindray M9 Ultrasound System.
Study NCT04183179 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Happy Family, Healthy Kids Program
Description: The 14-week healthy eating program activities including four components:~1. A 14-week parent Facebook-based program focusing on stress management and healthy eating to reduce emotional eating and increase parents' capacity to initiate healthy eating practices at home~2. Three parent face-to-face or virtual meetings at Head Start centers to connect parents with each other in person, offer healthy cooking tools/classes, and discuss behavioral change strategies and challenges~3. 14-week child Eat My ABCs program at Head Start centers to provide an age-appropriate, healthy eating program to children~4. Weekly child letter to parents to connect child learning at the Head Start center with parental practices at home
Study NCT04162353 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: BCMA-CD19 cCAR T cells
Description: BCMA-CD19 cCAR T cells administered to patients, will be either fresh or thawed CAR T cells by IV injection after receiving lymphodepleting chemotherapy
Study NCT05319613 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Virtual clinical visits with home lab kits and mailed HIV PrEP
Description: Rural participants who enter PrEP care with University of Colorado HIV Prevention Program will receive PrEP services via telemedicine with home lab kits and mailed HIV PrEP
Study NCT06445881 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Modified Si Jun Zi Tang
Description: Modified Si Jun Zi Tang is a classic formula in traditional Chinese medicine, known for its benefits in unifying and strengthening the spleen.
Study NCT04685070 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HS-10296 (Almonertinib)
Description: Neoadjuvant treatment stage: HS-10296 110mg, qd, po, 4 weeks per cycle, 2-4 cycles in total; Surgical treatment stage: CR + PR patients and SD + PD patients who could still undergo surgery will receive radical surgery; Adjuvant treatment stage: CR, PR and SD patients who have been treated surgically: HS-10296 110mg, qd, po, up to 48 weeks (including neoadjuvant stage). PD patients: transferred into medical oncology or/and radiation oncology and receive comprehensive therapy.
Study NCT05198752 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Neoantigen mRNA Personalised Cancer SW1115C3
Description: Subcutaneous Injection
Study NCT05539586 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Tecartherapy
Description: Patients will receive therapeutic exercise sessions for 7 weeks and 7 tecartherapy sessions.
Study NCT05539586 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham
Description: Patients will receive therapeutic exercise sessions for 7 weeks and 7 sessions of simulated tecartherapy.
Study NCT05565742 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY3819469
Description: Administered SC
Study NCT05968976 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Awake DBS
Description: 55 patients receive awake DBS (current standard procedure)
Study NCT05968976 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Asleep DBS
Description: 55 patients receive asleep DBS
Study NCT05565742 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Administered SC
Study NCT05565742 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Administered SC
Study NCT05289934 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Music Stimuli
Description: Nine-minute-long Mozart K.448 (1st movement) and instrumental age-appropriate songs will be played via single-use earbuds with 10 minutes wash-out in between music stimuli.
Study NCT05165472 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Quadri-pulse theta burst stimulation
Description: High frequency transcranial quadri-pulse theta burst stimulation prior to hand motor function training
Study NCT05165472 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Quadri-pulse theta burst stimulation
Description: High frequency transcranial quadri-pulse theta burst stimulation prior to hand motor function training
Study NCT06062693 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: smart sensor egg training
Description: The portable hand trainer has three principal functionalities: (I) Grasping, (II) Pronosupination, and (III) wrist and finger extension. Different exercises can be done.
Study NCT06635863 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prednisone 40mg
Description: Prednisone 40mg x 8weeks
Study NCT05931016 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: 6-MWT
Description: Measurement of saturation and blood gas parameters under 6-MWT with different masks.
Study NCT05931016 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Spiroergometry
Description: Measurement of saturation and blood gas parameters under spiroergometry with different masks.
Study NCT06516939 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: bFGF
Description: Half-face randomized control
Study NCT04999267 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: INVEST
Description: The intervention will consist of 3 primary components: 1) school nurse training and technical support for promoting adolescent vaccination (Tdap, MenACWY, HPV) and strengthening existing school nursing vaccination programming, 2) caregiver-targeted educational materials that are disseminated via school nurses, and 3) tools and resources to facilitate linkage to vaccination providers in the local community. Existing materials will be used in the intervention such as resources available from the Centers for Disease Control and Prevention and Middle School Health Starts Here tool kit from the National Association of School Nurses and the National HPV Roundtable. Technical support includes the study team working with local school nurses to identify educational materials available from national and statewide sources.
Study NCT05552365 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Adapted Cognitive Behavioural
Description: 8-session cognitive behavioural intervention adapted for children indicated to have developmental language disorder. Intervention includes psychoeducative, bodily relaxation, graded exposure, cognitive restructuring and brainstorming. Adaptations include increasing the number of visual supports, use of physical objects to illustrate concepts in addition to language.
Study NCT05552365 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Treatment as Usual
Description: Participants given a mental health brochure with contact information, where they can access services provided by mental health support service providers.
Study NCT05538728 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: poly-l-lactic acid (Sculptra)
Description: Sculptra
Study NCT05701826 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HRS3797
Description: HRS3797 for injection, low dose
Study NCT05701826 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HRS3797
Description: HRS3797 for injection, medium dose
Study NCT05701826 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HRS3797
Description: HRS3797 for injection, high dose
Study NCT06149169 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CD19-targeted Chimeric Antigen Receptor(CAR) T Cells
Description: Relma-cel be administered at one dose level:1×10\^8 CAR+T cells
Study NCT06271187 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Dynamic-orthosis
Description: Engaging in motion training at home with the use of dynamic orthoses.
Study NCT06271187 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Traditional stroke occupational therapy training
Description: Traditional post-stroke movement training arranged by an occupational therapist in a medical setting.
Study NCT06271187 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Traditional stroke occupational therapy training
Description: Traditional post-stroke movement training arranged by an occupational therapist in a medical setting.
Study NCT05737979 — intervention group
Intervention type: OTHER
Intervention: Study chart review
Description: Evaluation of the IVF cycle using the prescribed medication
Study NCT06184451 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Therapeutic exercise
Description: The therapeutic exercise program includes a warm-up, resistance, neuromuscular, mobility, and balance exercises. Therapeutic exercises will be performed in up to three sets of 8-12 repetitions or 30-60 seconds each, with rest intervals of 90 seconds between sets.
Study NCT06184451 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Therapeutic exercise
Description: The therapeutic exercise program includes a warm-up, resistance, neuromuscular, mobility, and balance exercises. Therapeutic exercises will be performed in up to three sets of 8-12 repetitions or 30-60 seconds each, with rest intervals of 90 seconds between sets.
Study NCT06184451 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation
Description: TENS will be applied with a portable device, Neurodyn Portable System from Ibramed, while carrying out the entire therapeutic exercise program. The equipment has a two-phase and pulsed symmetric quadratic waveform. 5x5cm adhesive electrodes will be applied to the lateral and medial edges and superior and inferior to the patella, in a crossed manner, surrounding the region.~The parameters established for the protocol of this study are based on a survey already carried out, with continuous pulse mode, frequency of 150Hz, duration of 150us, and amplitude varying from 1-60mA or more as long as tolerated by the study participant, without causing pain. The application time will be proportional to the time of the exercise session, approximately 60 minutes. The researcher will evaluate the need to adjust the current intensity through the pulse amplitude regularly so that the stimulus does not accommodate.